Question 1

What is Skinject?

Accepted Answer

Skinject is a Entity.

Question 2

How often does Skinject appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Skinject first tracked by Ergen?

Accepted Answer

First tracked on Jun 15, 2026.

Question 4

When was Skinject last mentioned in news?

Accepted Answer

Last active on Jun 15, 2026.

Question 5

What is Skinject's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Skinject in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Skinject?

Accepted Answer

Medicus Pharma Seeks SkinJect Designation (Jun 15, 2026, 6 articles).

Question 8

How did the "Medicus Pharma Seeks SkinJect Designation" event impact Skinject?

Accepted Answer

Skinject is an investigational microneedle patch developed by Medicus Pharma for treating basal cell carcinoma in Gorlin Syndrome patients. Its successful designation and approval could provide significant market exclusivity and accelerated review.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.